Drug Trial Radar · NCT06194461
LTFU for All Cell and Gene Therapy Studies
Last checked: Nov 19, 2026Latest source record: Jun 27, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
64
Planned (sponsor's estimate)
Start
Sep 17, 2025
Primary completion
Nov 29, 2041
Study completion Nov 29, 2041
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jan 8, 2024
Design
- Study type
- Observational
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Master LTFU study will monitor the long-term safety and tolerability of cell or gene therapy study participants from AstraZeneca for up to 15 years post last cell or gene therapy treatment.
Conditions
- Hepatocellular Carcinoma
- Prostate Cancer
Interventions
AZD5851Biological
Safety follow-up for up to 15 years of subjects who received AZD5851 in study NCT06084884.
AZD0754Biological
Safety follow-up for up to 15 years of subjects who received AZD0754 in study NCT06267729.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of specific AEsTime frame: Maximum of 15 years post dosing
Locations
25 sites in 4 countries. Site status is shown where the registry gives one.
Research Site
Phoenix, Arizona
Research Site
Duarte, California
Research Site
Orange, California
Research Site
San Francisco, California
Research Site
Washington D.C., District of Columbia
Research Site
Jacksonville, Florida
Research Site
Tampa, Florida
Research Site
Atlanta, Georgia
Research Site
Westwood, Kansas
Research Site
Rochester, Minnesota
Research Site
St Louis, Missouri
Research Site
Hackensack, New Jersey
Research Site
New York, New York
Research Site
Columbus, Ohio
Research Site
Portland, Oregon
Research Site
Philadelphia, Pennsylvania
Research Site
Pittsburgh, Pennsylvania
Research Site
Houston, Texas
Research Site
East Melbourne, Australia
Research Site
Kashiwa, Japan
Research Site
Kyoto, Japan
Research Site
Osakasayama-shi, Japan
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.